Loading clinical trials...
Loading clinical trials...
The investigators hypothesize that injections of Low molecular weight heparin (LMWH) \[enoxaparin\] will reduce pain in women with vulvodynia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Western Galilee Hospital-Nahariya
NCT07257029 · Provoked Vestibulodynia, Secondary Provoked Vestibulodynia, and more
NCT01829204 · Vulvodynia, Mycoses, and more
NCT06840314 · Genito-Pelvic Pain/Penetration Disorder, Dyspareunia, and more
NCT04711369 · Vulvodynia
NCT05955313 · Vulvodynia, Naltrexone, and more
Western Galilee Hospital- Nahariya
Nahariya
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions